Since both B16F10-OTI and B16F10 cells express gp100 but only B16F10-OTI can be recognized by OVA-specific Trm cells, these results suggest that melanoma recognition by Trm cells triggers the spreading of CD8+ T-cell responses to tumor-derived antigens. Here, CD8A is linked to neoplasm.